Madrigal Pharmaceuticals (MDGL) Revenue (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) revenue from Jun 30, 2010 to Mar 31, 2026. The TTM Madrigal Pharmaceuticals (MDGL) revenue is $1.13B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Madrigal Pharmaceuticals (MDGL) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +256.81% |
Annual Revenue change of Madrigal Pharmaceuticals (MDGL)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $311M | -67.51% |
| 2025 | $958M | +432.06% |
| 2024 | $180M | N/A |
| 2023 | $0 | N/A |
| 2022 | $0 | N/A |
| 2021 | $0 | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |
| 2018 | $0 | N/A |
| 2017 | $0 | N/A |
| 2016 | $0 | N/A |
| 2015 | $0 | N/A |
| 2014 | $0 | N/A |
| 2013 | $0 | -100.00% |
| 2012 | $150K | N/A |
| 2011 | $0 | N/A |
| 2010 | $0 | N/A |
| 2009 | $0 | N/A |